Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Pharmaceutical Preparations

GH Power Inc. to acquire Matinas BioPharma Holdings, Inc.

Announced Jul 13, 2026 · Closed Jul 13, 2026

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock

Transaction

Acquirer
GH Power Inc.
Target
Matinas BioPharma Holdings, Inc. (MTNB)
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Jul 13, 2026

Deal protections

Break fee (target pays)
$1.0M
Reverse fee (buyer pays)
$1.0M
Go-shop
No-shop
Financing
—

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Sector context · Healthcare

Comparable deals
98 in the prior 24 months
Premium
Sector median 49.0%
EV / Adj. EBITDA
Sector median 10.9x
Break fee
Sector median 3.5%

Timeline

  1. AnnouncedJul 13, 2026
  2. ClosedJul 13, 2026
Sources
  • 8-K · Jul 13, 2026

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.